Mirae Asset Global ETFs Holdings’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-66,786
Closed -$58.5K 3182
2025
Q1
$58.5K Buy
66,786
+7,283
+12% +$10.1K ﹤0.01% 2820
2024
Q4
$101K Buy
59,503
+2,690
+5% +$4.85K ﹤0.01% 2696
2024
Q3
$109K Buy
56,813
+34,035
+149% +$77.3K ﹤0.01% 2680
2024
Q2
$56K Buy
+22,778
New +$61.1K ﹤0.01% 2763

Other funds holding PROK

Mirae Asset Global ETFs Holdings's PROK Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of ProKidney (PROK) in Q2 2025, closing a stake of 66,786 shares — an estimated $58.5K sold.

Mirae Asset Global ETFs Holdings first reported a position in PROK in Q2 2024 and held it in 4 quarters. The position peaked at $109K in Q3 2024. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 66,786 ProKidney shares in Q2 2025, an estimated $58.5K.
  • Mirae Asset Global ETFs Holdings first reported a position in ProKidney in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's ProKidney position peaked at $109K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.